tiprankstipranks
Peterson Reaffirms Buy Rating for Cardlytics Amid Strong Financial Performance and Resolved Legal Uncertainties
Blurbs

Peterson Reaffirms Buy Rating for Cardlytics Amid Strong Financial Performance and Resolved Legal Uncertainties

Kyle Peterson, an analyst from Needham, reiterated the Buy rating on Cardlytics (CDLXResearch Report). The associated price target is $12.00.

Kyle Peterson’s Buy rating for Cardlytics (CDLX) stems from several key observations and positive financial indicators. Firstly, Peterson notes that Cardlytics’ preliminary fourth-quarter results suggest that both billings and revenue are trending towards the upper end of their previously issued guidance. Additionally, the EBITDA is anticipated to surpass the company’s forecasts, reflecting the successful implementation of cost efficiency measures. This financial performance is particularly notable given the uncertain economic climate.

Moreover, Peterson views the resolution of disputes with SRS regarding Bridg earnout payments as a pivotal moment. The settlement, which includes a $25 million cash payment and the issuance of 3.6 million common shares to former Bridg shareholders, effectively removes a considerable uncertainty that had been looming over the company. He believes that this resolution, coupled with the solid fundamental results, positions Cardlytics favorably and that the market will respond well to these developments. Consequently, Peterson reiterates his Buy rating, signaling confidence in the company’s near-term prospects.

In another report released yesterday, Lake Street also reiterated a Buy rating on the stock with a $13.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CDLX in relation to earlier this year.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Cardlytics (CDLX) Company Description:

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Read More on CDLX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles